Association between hypothyroidism and small intestinal bacterial overgrowth
Abstract
OBJECTIVES: Small intestinal bacterial overgrowth is defined as an abnormally high bacterial population level in the small intestine. Intestinal motor dysfunction associated with hypothyroidism could predispose to bacterial overgrowth. Luminal bacteria could modulate gastrointestinal symptoms and interfere with levothyroxine absorption. The aims of the present study were to assess the prevalence and clinical pattern of bacterial overgrowth in patients with a history of overt hypothyroidism and the effects of bacterial overgrowth decontamination on thyroid hormone levels. METHODS: A total of 50 consecutive patients with a history of overt hypothyroidism due to autoimmune thyroiditis was enrolled. Diagnosis of bacterial overgrowth was based on positivity to a hydrogen glucose breath test. Bacterial overgrowth positive patients were treated with 1,200 mg rifaximin each day for a week. A glucose breath test, gastrointestinal symptoms, and thyroid hormone plasma levels were reassessed 1 month after treatment. RESULTS: A total of 27 patients with a history of hypothyroidism demonstrated a positive result to the breath test (27 of 50, 54%), compared with two in the control group (two of 40, 5%). The difference was statistically significant (P < 0.001). Abdominal discomfort, flatulence, and bloating were significantly more prevalent in the bacterial overgrowth positive group. These symptoms significantly improved after antibiotic decontamination. Thyroid hormone plasma levels were not significantly affected by successful bacterial overgrowth decontamination. CONCLUSIONS: The history of overt hypothyroidism is associated with bacterial overgrowth development. Excess bacteria could influence clinical gastrointestinal manifestations. Bacterial overgrowth decontamination is associated with improved gastrointestinal symptoms. However, fermenting carbohydrate luminal bacteria do not interfere with thyroid hormone levels.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Nearly 54% of hypothyroidism patients show presence of bacterial overgrowth in the small intestine.
“Nearly 54% of hypothyroidism patients show presence of bacterial overgrowth in the small intestine (Lauritano et al., 2007).”
From Thyroid disorders and gastrointestinal dysmotility: an old association (2024) · cites this paper as Lauritano et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 45 · Cited by 140
Research works printed but not linked: 1
- Kissel JT, Mendell JR 1992 The endocrine myopathies. In: Rowland LP, DiAauro S, eds. Handbook of clinical neurology. Vol 18. Amsterdam: Elsevier Science Publisher; 527-551
- Authors
- Lauritano, E. C., Bilotta, A. L., Gabrielli, M., Scarpellini, E., Lupascu, A., Laginestra, A., Novi, M., Sottili, S., Serricchio, M., Cammarota, G., Gasbarrini, G., Pontecorvi, A., & Gasbarrini, A.
- Affiliations
- Università Cattolica del Sacro Cuore (IT)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-11
- Volume
- 92
- Issue
- 11
- Pages
- 4180-4184
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2081847108
- Cited by
- 140
- References
- 45
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 10 · 2023: 14 · 2022: 15 · 2021: 12 · 2020: 16 · 2019: 8 · 2018: 2 · 2017: 5 · 2016: 4 · 2015: 8 · 2014: 10 · 2013: 3 · 2012: 3
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Keywords
- small intestinal bacterial overgrowth, hypothyroidism, overt hypothyroidism, autoimmune thyroiditis, rifaximin, antibiotic decontamination, gastrointestinal symptoms, flatulence, bloating, thyroid hormone levels
- MeSH terms
- Rifaximin, Adult, Anti-Bacterial Agents, Bacteria, Breath Tests, Data Interpretation, Statistical, Decontamination, Female, Gastrointestinal Agents, Humans, Hydrogen, Hypothyroidism, Intestine, Small, Male, Rifamycins, Thyroid Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review